Molecular Analysis of Glycopeptide-ResistantEnterococcus faecium Isolates Collected from Michigan Hospitals over a 6-Year Period

ABSTRACT The purpose of this study was to evaluate the molecular relatedness of clinical isolates of glycopeptide-resistant Enterococcus faecium isolates collected from hospitals in Michigan. A total of 379 isolates used in this study were all vancomycin-resistant E. faecium isolates collected from 28 hospitals and three extended-care facilities over a 6-year period from 1991 to 1996. For the 379 isolates, there were 73 pulsed-field gel electrophoresis (PFGE) strain types. Within strain types, there were as many as six restriction fragment differences. Most isolates (70%) belonged to six strain types, which were designated M1 (36%), M2 (3%), M3 (18%), M4 (6%), M10 (4%), and M11 (3%). PFGE strain M1 was cultured from 135 patients in 13 hospitals during the period 1993 to 1996. Strain type M2 was cultured from 11 patients in two hospitals during the period 1991 to 1992 and was not observed after 1992. Strain type M3 was cultured from 70 patients in 10 hospitals during the period of 1994 to 1996. Both M4 and M10 were cultured from 23 patients in three hospitals and from 15 patients in two hospitals, respectively, during 1995 to 1996. M11 was cultured from 13 patients in four hospitals during 1996. A total of 23 of 28 hospitals had evidence of clonal dissemination of some isolates. Plasmid content and hybridization analysis done on 103 isolates from one hospital and two affiliated extended-care facilities indicated that the strains contained from one to eight plasmids. Mating experiments indicated transfer of vancomycin resistance from 94 of these isolates into plasmid-free E. faecium GE-1 at transfer frequencies of <10−9 to 10−4. Gentamicin resistance and erythromycin resistance were cotransferred at various frequencies. A probe for the vanA gene hybridized to the plasmids of 23 isolates and to the chromosomes of 72 isolates. A probe for the vanB gene hybridized to the chromosomes of 8 isolates. The results of this study suggest inter- and intrahospital dissemination of vancomycin-resistant E. faecium strains over a 6-year period in southeastern Michigan. The majority of isolates studied belonged to the same few PFGE strains, indicating that clonal dissemination was responsible for most of the spread of resistance that occurred.

[1]  K. Singh,et al.  Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Collins,et al.  Identification of Enterococcus species isolated from human infections by a conventional test scheme , 1989, Journal of clinical microbiology.

[3]  J. Boyce,et al.  Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance , 1994, Journal of clinical microbiology.

[4]  M. Arthur,et al.  Genetics and mechanisms of glycopeptide resistance in enterococci , 1993, Antimicrobial Agents and Chemotherapy.

[5]  F. Moreno,et al.  Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  R. Arduino,et al.  High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  G. Eliopoulos,et al.  A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci , 1993, Antimicrobial Agents and Chemotherapy.

[8]  G. Trenholme,et al.  In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. , 1993, The Journal of infectious diseases.

[9]  R. Gaynes,et al.  Major trends in the microbial etiology of nosocomial infection. , 1991, The American journal of medicine.

[10]  W. Witte,et al.  Glycopeptide-resistant Enterococcus faecium outside Hospitals: a commentary. , 1995, Microbial drug resistance.

[11]  T. Frieden,et al.  Emergence of vancomycin-resistant enterococci in New York City , 1993, The Lancet.

[12]  P. Coudron,et al.  Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas , 1992, Journal of clinical microbiology.

[13]  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993. , 1993, MMWR. Morbidity and mortality weekly report.

[14]  S. Handwerger,et al.  Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States , 1995, Antimicrobial agents and chemotherapy.

[15]  W. Martone,et al.  Predominant pathogens in hospital infections. , 1992, The Journal of antimicrobial chemotherapy.

[16]  J. Waitz Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[17]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[18]  F. Tenover,et al.  Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers , 1994, Journal of clinical microbiology.

[19]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[20]  M. Zervos,et al.  Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states , 1993, Journal of clinical microbiology.

[21]  R. Leclercq,et al.  Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. , 1996, The Journal of infectious diseases.

[22]  F. Tenover,et al.  Characterization of glycopeptide-resistant enterococci from U.S. hospitals , 1993, Antimicrobial Agents and Chemotherapy.

[23]  Ronald N. Jones,et al.  Molecular Analysis of Tn1546 inEnterococcus faecium Isolated from Animals and Humans , 1998, Journal of Clinical Microbiology.

[24]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[25]  M. Zervos,et al.  Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. , 1987, Annals of internal medicine.